TP53 missense mutations, which typically affect the DNA-binding domain, are recurrent in high-grade gliomas, MB, pediatric adrenocortical carcinoma, and leukemias, leading to loss of tumor suppressor function and impaired genomic stability [131,132,133,134]. The gene discussed is TP53; the disease is neoplasm.